In the News

Color Genomics Partners with University of California Health System in Landmark Athena WISDOM Study

Color Genomics Partners with University of California Health System in Landmark Athena WISDOM Study

October 22, 2015 12:00 PM Eastern Daylight Time
BURLINGAME, Calif.--(BUSINESS WIRE)--We are excited to announce that Color has been selected as the genomics partner for the Athena WISDOM Study, a $14.1 million-funded University of California (UC) Health system-wide program in collaboration with Salesforce and Blue Shield of California. The WISDOM Study was selected by the Patient-Centered Outcomes Research Institute (PCORI) for its potential to impact patient outcomes and significantly improve women's health. Led by Dr. Laura Esserman, MD, MBA, Professor of Surgery and Director of the Carol Franc Buck Breast Care Center at UCSF and supported by Salesforce, Blue Shield of California and PCORI, the study will investigate whether a personalized approach to breast cancer screening based on risk profile is more effective than a one-size-fits-all approach to breast screening.

The WISDOM Study will include approximately 100,000 women over 5 years, and will be coordinated across the 5 UC medical centers - UCSF, UCLA, UCSD, UCSC, UC Davis, as well as Sanford Health in the Midwest region. Based on the results of the Color Test and other risk indicators, including family and medical history and breast density, women in one arm of the study will be offered a personalized breast cancer screening plan (e.g. mammography and other imaging techniques) that is tailored to their risk profile. You can read more about the Athena WISDOM study and its potential impact to patients, screening, and cost savings to the healthcare system here.

Fierce Biotech IT

Read More